Nicotine/mecamylamine transdermal patch data

Researchers presented Phase II findings with the combination patch at the World Conference on Tobacco and Health in Beijing, with success indicated by a decrease in cigarettes smoked and decline in craving by self-report. Phase III testing is underway with results expected this year, SANO said.

Mecamylamine is a generic drug marketed for hypertension. It is an antagonist at nicotine receptors, reducing the pleasurable effects of smoking. ...